MedPath

Cimetidine in the treatment of primary dysmenorrhea

Not Applicable
Conditions
Primary dysmenorrhoea.
Primary dysmenorrhoea
Registration Number
IRCT2013051212701N2
Lead Sponsor
Semnan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
90
Inclusion Criteria

age 22-18 years old; one year of regular menstrual cycle; the first three days of menstruation; menstrual complaints of pain; pain cycle so that more medication may be needed.
Exclusion criteria: lack of sufficient cooperation; BMI more than 26; history of gastrointestinal disease, such as I BS; urological disease (repetition burning urination); Endometriosis; Epilepsy; genital system disorders such as infectious disease; previous abdominal surgery; a history full term pregnancy; - a history of sensitivity to cimetidine; drugs interaction with cimetidine for example: Warfarin - phenytoin - Inderal - nifedipine. Diazepam and antidepressants - Lidocaine - theophylline - metronidazole; use of other drugs to reduce the pain of dysmenorrhea.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Analgesia. Timepoint: For 6 months after intervention. Method of measurement: Numeric Rating Pain Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath